[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335560-105":59,"doc-detail-335560-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","exploring-the-effect-of-fidgetin-like-1-on-colorectal-cancer-through-tissue-chip-and-in-vitro-experiments","Exploring the Effect of Fidgetin-Like 1 on Colorectal Cancer Through Tissue Chip and In Vitro Experiments","","Fidgetin-like 1 (FIGNL1) is overexpressed across multiple cancers, yet its role in colorectal cancer (CRC) remains unclear. This study investigated whether FIGNL1 influences CRC progression and defined related mechanisms. TCGA and immunohistochemistry assessed FIGNL1 expression, while Cell Counting Kit-8, transwell assays, and siRNA knockdown evaluated proliferation, migration, and invasion. FIGNL1 overexpression lentivirus tested gain-of-function effects, and STRING prediction supported pathway analysis. FIGNL1 was elevated in CRC and linked to TNM stage and lymph node metastasis, and it promoted CRC cell aggressive behavior via P38 signaling contingent on SPIDR interaction.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exploring-the-effect-of-fidgetin-like-1-on-colorectal-cancer-through-tissue-chip-and-in-vitro-experiments/335560/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exploring-the-effect-of-fidgetin-like-1-on-colorectal-cancer-through-tissue-chip-and-in-vitro-experiments/335560.png","ImageObject",300,407,{"name":92,"@type":93},"Seraphina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the purpose of this study on FIGNL1 in colorectal cancer?","Question",{"text":112,"@type":113},"To investigate the function of FIGNL1 in colorectal cancer (CRC) and clarify its involvement in CRC progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was FIGNL1 expression assessed in CRC tissues?",{"text":117,"@type":113},"The TCGA database and immunohistochemistry analysis were used to evaluate FIGNL1 expression in CRC tissue.",{"name":119,"@type":110,"acceptedAnswer":120},"What cellular and molecular effects did FIGNL1 show in CRC models?",{"text":121,"@type":113},"Silencing FIGNL1 inhibited CRC cell proliferation, migration, and invasion, while FIGNL1 overexpression promoted these behaviors through P38 signaling, depending on SPIDR interaction.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335560,1790366186,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":4},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","Original Article  491  \nContent of this journal is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.  \nBalkan Med J 2024;41:491-8  \nExploring the Effect of Fidgetin-Like 1 on Colorectal Cancer Through  \nTissue Chip and In Vitro Experiments  \n Yunxing Xu\\# ,  Yucheng Shen\\# ,  Chen Zhang,  Liangfeng Zheng,  Feiyue Ji,  Jin Chen,  Shouliang Cheng,  \n Yu Zheng  \nClinic of Central Laboratory, Hai’an City People’s Hospital of Jiangsu Province, Hai’an Hospital Affiliated to Nantong University, Nantong, China  \n\\#These authors contributed equally to this work.  \nBackground: Fidgetin-like 1 (FIGNL1) is extensively overexpressed in a variety of cancers. It facilitates non-small cell lung cancer tumor cell proliferation and hepatocellular carcinoma formation due to abnormal DNA repair. Clinically relevant data indicates that its high expression is linked with the poor prognosis of patients with renal clear-cell carcinoma, low-grade gliomas, and hepatocellular carcinoma. Nevertheless, the scope of FIGNL1’s involvement in cancer, particularly colorectal cancer (CRC), remains unclear.  \nAims: To investigate the function of FIGNL1 in CRC.  \nStudy Design: Cell culture study  \nMethods: The TCGA database and immunohistochemistry analysis were employed to investigate FIGNL1 expression in CRC tissue. A cell viability assay was performed using the Cell Counting Kit-8 . The cell migration and invasion were evaluated using the transwell assay. Small interfering RNA  \n(siRNA) transfection was conducted to knockdown FIGNL1 expression. Infection with FIGNL1 overexpression lentivirus was performed to promote FIGNL1 overexpression. The STRING database was employed for predicting protein interaction.  \nResults: FIGNL1 was substantially upregulated in human CRC tissues and was associated with TNM stages and lymph node metastasis in patients. The inhibition of CRC cell proliferation, migration, and invasion in Caco-2 cells was achieved by silencing FIGNL1 using siRNA. Additional investigations suggested that FIGNL1 overexpression could promote CRC cell proliferation, migration, and invasion via P38 signaling pathway activation in Colo-205 cells. Subsequent experiments demonstrated that FIGNL1-mediated P38 phosphorylation was contingent upon SPIDR interaction.  \nConclusion: These results implied that FIGNL1 was a potential anticancer drug target, which also offered a novel strategy for future CRC treatment.  \nINTRODUCTION  \nColorectal cancer (CRC), a common digestive tract malignancy, is the third most lethal form of cancer worldwide.1 Its etiology is complex, owing primarily to the synergistic effect of environment, diet, lifestyle, and genetic factors. The development of CRC is relatively insidious and gradual, as it typically takes 10-15 years for normal intestinal epithelial cells to undergo neoplastic transformation. By the time the patients experience clinical symptoms, CRC has often progressed to the middle and advanced stages.2 With the development of novel targeted therapies and technological innovation, the use of immunotherapy for tumors is progressively becoming more prevalent in clinics. For instance, the immunosuppressant epidermal  \ngrowth factor receptor antibody exhibits remarkable efficacy in 50- 60% of patients who lack RAS and BRAF gene mutations.3 However, CRC-associated mortality rates continue to be elevated. Given the current state of clinical detection and treatment, it is imperative to explore novel clinical markers or drug targets to provide additional benefits to CRC patients.  \nThe Fidgetin-like 1 (FIGNL1) protein is a member of the ATPase subgroup, which is associated with cellular active proteins. It is recruited to DNA damage sites to repair double-strand breaks of DNA, which are dependent on homologous recombination. A previous study has reported that FIGNL1 is a novel inhibitor for the formation of super-hybridized rice as it regulates DMC1  \nCorresponding author: Yu Zheng,","cbCaivcAUD35YFKm","https://ap.wps.com/l/cbCaivcAUD35YFKm","pdf",1818907,"English","# Background\n## Aims\n## Study Design\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the purpose of this study on FIGNL1 in colorectal cancer?\",\"answer\":\"To investigate the function of FIGNL1 in colorectal cancer (CRC) and clarify its involvement in CRC progression.\"},{\"question\":\"How was FIGNL1 expression assessed in CRC tissues?\",\"answer\":\"The TCGA database and immunohistochemistry analysis were used to evaluate FIGNL1 expression in CRC tissue.\"},{\"question\":\"What cellular and molecular effects did FIGNL1 show in CRC models?\",\"answer\":\"Silencing FIGNL1 inhibited CRC cell proliferation, migration, and invasion, while FIGNL1 overexpression promoted these behaviors through P38 signaling, depending on SPIDR interaction.\"}]","Exploring the Effect of Fidgetin-Like 1 on Colorectal Cancer Through Tissue Chip and In Vitro Experiments | PDF",1790011445]